People might attribute midnight bouts of chest pain or waves of nausea to food poisoning, stress or a stubborn case of indigestion, but Rutgers Health researchers suggest that knowing your family's ...
Biliary atresia (BA) is a rare, progressive inflammatory disease of the biliary system that is the leading cause of neonatal cholestasis, characterised by fibrosis and obliteration of the bile ducts.
The National Institute for Health and Care Excellence (NICE) has recommended durvalumab (IMFINZI, AstraZeneca) with gemcitabine and cisplatin as an option for treating locally advanced, unresectable, ...
The liver produces bile, which the intestine uses for digestion. For the transport of bile, the liver relies on a network of microscopic tubings, known as bile canaliculi, formed by liver cells called ...
American Liver Foundation (ALF) applauds the Agency for Healthcare Research and Quality (AHRQ) on their groundbreaking report that assesses the prevalence of nonalcoholic fatty liver disease (NAFLD), ...
Credit: Jazz Pharmaceuticals Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor. Findings showed the ORR was 52% (95% CI, 39-65), of which ...
At its April 2025 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave a conditional marketing authorization for Ziihera (zanidatamab, Jazz ...
The biliary tract cancer epidemiology section provides insights into the historical and current biliary tract cancer patient pool and forecasted trends for the leading markets. In 2024, the majority ...
An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements. In the treatment of newly diagnosed biliary tract cancer, the current standard ...
A Danish cohort study found higher levels of the inflammation marker SCD163 were associated with lower quality of life in primary biliary cholangitis patients. When Patients with Primary Sclerosing ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted accelerated approval to zanidatamab-hrii for treatment of adults with previously treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results